RSNA 2019 News

iCAD features AI software for breast imaging at RSNA

By staff writers
December 4, 2019

Computer-aided detection (CAD) software developer iCAD is showcasing its Breast Health Solutions suite, including the expanded ProFound AI platform, at RSNA 2019 in Chicago.

ProFound AI for digital breast tomosynthesis (DBT) is the first artificial intelligence (AI) software for DBT to be cleared by the U.S. Food and Drug Administration, according to iCAD. The company will also feature software for 2D mammography and breast density.

In addition, iCAD will discuss plans for the future, including software that lets clinicians consider patients' prior images and prospective breast cancer risk assessment over time.

iCAD features Xoft Axxent upgrades at ASTRO 2019
Computer-aided detection (CAD) software developer iCAD is showcasing the latest updates for its Xoft Axxent electronic brachytherapy machine at this week's...
iCAD partners with Swedish team on AI for breast cancer
Computer-aided detection (CAD) developer iCAD will collaborate with researchers from the Karolinska Institute in Stockholm on developing an artificial...
iCAD to highlight AI for tomosynthesis at ECR
iCAD plans to highlight its artificial intelligence (AI) software for digital breast tomosynthesis, ProFound AI, at the upcoming ECR 2019 in Vienna.
iCAD gets FDA nod for ProFound AI software for DBT
iCAD has received U.S. Food and Drug Administration (FDA) clearance for its ProFound AI artificial intelligence (AI) software for analyzing digital breast...
iCAD touts clinical results with Xoft Axxent brachytherapy
iCAD is highlighting positive clinical results for its Xoft Axxent electronic brachytherapy system that were presented at this week's American Society...

Copyright © 2019